MFN Impact on Patients
The American Cancer Society’s Cancer Action Network is working in every state across the country. They worry, “the executive order involving Medicare drug coverage creates significant questions around drug accessibility, which could potentially make it much harder for cancer patients to get the drugs necessary to treat their disease.”
MFN Impact on Providers
The American College of Rheumatology (ACR) is dedicated to improving the care of patients with rheumatic diseases like arthritis that cause the immune system to attack joints, muscles, bones and organs. ACR has determined that, “the (MFN) rule threatens the financial solvency of many rheumatology practices… and jeopardizes the ability of rheumatologists to provide treatments to patients most in need. This will be detrimental to provider solvency and patient access to medications.”